These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 32643482)

  • 21. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
    Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH
    J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recipient-to-Donor Ratios in the Surgical Treatment of Vitiligo, Leukoderma, and Piebaldism: A Retrospective Review.
    Maghfour J; Bardhi R; Huggins R; Hamzavi IH; Mohammad TF
    Dermatology; 2023; 239(5):828-831. PubMed ID: 37231873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation.
    Zhang D; Wei X; Hong W; Fu L; Qian G; Xu AE
    Aging (Albany NY); 2021 Feb; 13(4):5415-5425. PubMed ID: 33582653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.
    Huggins RH; Henderson MD; Mulekar SV; Ozog DM; Kerr HA; Jabobsen G; Lim HW; Hamzavi IH
    J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of autologous non-cultured melanocyte keratinocyte transplantation in vitiligo and nevus depigmentosus.
    Sritanyarat T; Wongpraparut C; Jansuwan N; Yothachai P; Nuntawisuttiwong N; Silpa-Archa N
    J Dermatolog Treat; 2022 Mar; 33(2):935-940. PubMed ID: 32643482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of noncultured melanocyte-keratinocyte transplant procedure for vitiligo and other leukodermas: a critical analysis of the evidence.
    Vakharia PP; Lee DE; Khachemoune A
    Int J Dermatol; 2018 Jul; 57(7):770-775. PubMed ID: 29318598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical guidelines for the treatment of vitiligo with the melanocyte-keratinocyte transplantation procedure.
    Yousif J; Ceresnie MS; Hamzavi IH; Mohammad TF
    Arch Dermatol Res; 2023 Dec; 316(1):10. PubMed ID: 38038734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitiligo coexistent with nevus depigmentosus.
    Kang IK; Hann SK
    J Dermatol; 1996 Mar; 23(3):187-90. PubMed ID: 8935629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of traditional and surgical treatment modalities in segmental vitiligo: A review article.
    Khalili M; Amiri R; Mohammadi S; Iranmanesh B; Aflatoonian M
    J Cosmet Dermatol; 2022 Jun; 21(6):2360-2373. PubMed ID: 35253324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitiligo Surgery: Shuffling Melanocytes.
    Nahhas AF; Mohammad TF; Hamzavi IH
    J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S34-S37. PubMed ID: 28941491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous non-cultured melanocyte-keratinocyte transplantation in the treatment of vitiligo: patient selection and perspectives.
    Bassiouny D; Esmat S
    Clin Cosmet Investig Dermatol; 2018; 11():521-540. PubMed ID: 30464567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical approaches for stable vitiligo.
    Falabella R
    Dermatol Surg; 2005 Oct; 31(10):1277-84. PubMed ID: 16188179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The story of melanocyte: a long way from bench to bedside.
    Shahbazi A; Zargar SJ; Aghdami N; Habibi M
    Cell Tissue Bank; 2024 Mar; 25(1):143-157. PubMed ID: 37046149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.
    Birlea SA; Costin GE; Roop DR; Norris DA
    Med Res Rev; 2017 Jul; 37(4):907-935. PubMed ID: 28029168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanocyte-keratinocyte transplantation procedure: A few insights.
    Mulekar SV
    Indian J Dermatol Venereol Leprol; 2016; 82(1):13-5. PubMed ID: 26728804
    [No Abstract]   [Full Text] [Related]  

  • 37. Modalities of treatment for Nevus depigmentosus: review of the literature.
    Altalhab S
    J Dermatolog Treat; 2023 Dec; 34(1):2258241. PubMed ID: 37700698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of the vitiligo area scoring index in clinical studies of patients with vitiligo: a scoping review.
    Ceresnie MS; Warbasse E; Gonzalez S; Pourang A; Hamzavi IH
    Arch Dermatol Res; 2023 Oct; 315(8):2233-2259. PubMed ID: 37029284
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.